Where does Encodia, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Encodia, Inc. ranks #15,252 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Encodia, Inc. hold?

Encodia, Inc. holds 19 US utility patents granted between 2021 and 2025, spanning 8 technology areas.

What is Encodia, Inc.'s Innovation Score?

Encodia, Inc. has an Innovation Score of 53.2 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Encodia, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Encodia, Inc..

What does claim depth mean for Encodia, Inc.'s patents?

Encodia, Inc.'s patents average 21.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Encodia, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Encodia, Inc.

Q: What technology areas does Encodia, Inc. focus on?

Encodia, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 16 patents, ranking #665 of 4,144 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 19 granted patents across 8 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Encodia ranks #15,252 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 8 technology areas.

#15,252
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.2/100): 21.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R15252 · US Corporation #15,252 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 19 grants
MID-PACK #15,252/49,997
PHOTO-FINISH Eit Emerging Implant
CPC-NARROW C12N · 8 areas
INNOV-PAR 53.2/100
CLAIMS-DENSE 21.5 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Eit Emerging Implant Technologies GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Encodia’s 53.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (19%) Velocity 20.0 pts (38%) Breadth 10.0 pts (19%) Claim depth 12.9 pts (24%)

Qualcomm Incorporated · highest

85
Daiichi Kigenso… · near

53
Encodia · this assignee

53
Pinterest · near

53
Two Six Labs · near

53
University Hospitals… · near

53
3D Lighting… · lowest

7

What this shows Encodia's Innovation Score is 53.2/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Encodia?

Each dot is one of Encodia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Encodia’s own 21.5 claims/patent is ABOVE the 18.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Encodia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Encodia's grants concentrate

Encodia, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 84.2% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2024 (7 grants) versus a trough of 1 in 2021. By volume, Encodia sits between Eit Emerging Implant Technologies GmbH and Espera-Werke GmbH.

Encodia's three-year grant acceleration

Encodia, Inc. shows 14 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Eit Emerging Impl…

19
Elucent Medical

19
Embody

19
Emerson Vulcan Ho…

19
Endostim

19
Endochoice Innova…

19
Epic Lift Systems

19
Espera-werke

19
Encodia ◀

19

What this shows Encodia holds 19 patents at rank #15,255, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Encodia

By rank, the assignees closest to #15,255 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Encodia's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Encodia, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Encodia ranks #665 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (53 here).

Two Six Labs, LLC 53 Daiichi Kigenso Kagaku Kogyo Co., Ltd. 53 Pinterest, Inc. 53 University Hospitals Cleveland Medical Center 53

Encodia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Encodia, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	5.3%
2022	2	10.5%
2023	5	26.3%
2024	7	36.8%
2025partial year	4	21.1%

Which technologies does Encodia, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 16

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 14

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 14

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 11

C07K - Peptides 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

C07C - Acyclic OR Carbocyclic Compounds 1

C07D - Heterocyclic Compounds 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Encodia, Inc.'s patent record in context - here's where to go next.

Encodia, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 84.2% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #15,252 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Encodia, Inc. against Eit Emerging Implant Technologies GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.